MACKENZIE FINANCIAL CORP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$427,427
+123.2%
18,788
+47.5%
0.00%
Q1 2023$191,534
-23.1%
12,735
+70.1%
0.00%
Q3 2021$249,000
-70.9%
7,487
-76.6%
0.00%
-100.0%
Q3 2020$855,00031,9400.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders